173 related articles for article (PubMed ID: 18724281)
1. Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007.
Goldman J
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S11-S13. PubMed ID: 18724281
[TBL] [Abstract][Full Text] [Related]
2. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
Simon W; Segel GB; Lichtman MA
Blood Cells Mol Dis; 2006; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
[TBL] [Abstract][Full Text] [Related]
3. Clinical decisions for chronic myeloid leukemia in the imatinib era.
Goldman JM; Marin D; Olavarria E; Apperley JF
Semin Hematol; 2003 Apr; 40(2 Suppl 2):98-103; discussion 104-13. PubMed ID: 12783383
[TBL] [Abstract][Full Text] [Related]
4. Management decisions in chronic myeloid leukemia.
Goldman JM; Marin D
Semin Hematol; 2003 Jan; 40(1):97-103. PubMed ID: 12563616
[TBL] [Abstract][Full Text] [Related]
5. First-Line management of CML: a state of the art review.
Hochhaus A
J Natl Compr Canc Netw; 2008 Mar; 6 Suppl 2():S1-S10. PubMed ID: 18397676
[TBL] [Abstract][Full Text] [Related]
6. Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.
Giralt SA; Arora M; Goldman JM; Lee SJ; Maziarz RT; McCarthy PL; Sobocinski KA; Horowitz MM;
Br J Haematol; 2007 Jun; 137(5):461-7. PubMed ID: 17459051
[TBL] [Abstract][Full Text] [Related]
7. Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
Pulsipher MA
Pediatr Blood Cancer; 2004 Oct; 43(5):523-33. PubMed ID: 15382266
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies for CML.
Goldman JM
Best Pract Res Clin Haematol; 2009 Sep; 22(3):303-13. PubMed ID: 19959082
[TBL] [Abstract][Full Text] [Related]
9. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Burke MJ; Trotz B; Luo X; Weisdorf DJ; Baker KS; Wagner JE; Verneris MR
Bone Marrow Transplant; 2009 Aug; 44(3):169-74. PubMed ID: 19204709
[TBL] [Abstract][Full Text] [Related]
10. [An advance in the treatment of CML].
Ohnishi K
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2185-90. PubMed ID: 18079618
[TBL] [Abstract][Full Text] [Related]
11. Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Atallah E; Cortes J
Curr Opin Hematol; 2007 Mar; 14(2):138-44. PubMed ID: 17255791
[TBL] [Abstract][Full Text] [Related]
12. [Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation].
Igarashi T; Hayashi T; Yasui H; Ikeda H; Takahashi T; Ishida T; Shinomura Y
Rinsho Ketsueki; 2012 Feb; 53(2):215-8. PubMed ID: 22450581
[TBL] [Abstract][Full Text] [Related]
13. Transplantation for chronic myelogenous leukemia: yes, no, maybe so. . . An Oregon perspective.
Maziarz RT; Mauro MJ
Bone Marrow Transplant; 2003 Sep; 32(5):459-69. PubMed ID: 12942091
[TBL] [Abstract][Full Text] [Related]
14. Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin R; Martinelli G; Baccarani M
Bone Marrow Transplant; 2007 Feb; 39(3):189-91. PubMed ID: 17211436
[No Abstract] [Full Text] [Related]
15. Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
Ruiz-Argüelles GJ; Tarin-Arzaga LC; Gonzalez-Carrillo ML; Gutierrez-Riveroll KI; Rangel-Malo R; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Gómez-Almaguer D; Giralt S
Bone Marrow Transplant; 2008 Jul; 42(1):23-8. PubMed ID: 18612313
[TBL] [Abstract][Full Text] [Related]
16. Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib era.
Grigg A; Hughes T
Biol Blood Marrow Transplant; 2006 Aug; 12(8):795-807. PubMed ID: 16864049
[TBL] [Abstract][Full Text] [Related]
17. Role of allogeneic transplantation in chronic myeloid leukemia.
Heim D; Gratwohl A
Expert Rev Hematol; 2008 Oct; 1(1):41-50. PubMed ID: 21083006
[TBL] [Abstract][Full Text] [Related]
18. Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic stem cell transplantation in CML.
Weisser M; Schmid C; Schoch C; Hiddemann W; Kolb HJ
Bone Marrow Transplant; 2005 Dec; 36(11):1017-8. PubMed ID: 16184176
[No Abstract] [Full Text] [Related]
19. [Stem cell transplantation in the imatinib era].
Masszi T
Orv Hetil; 2005 May; 146(18 Suppl 1):900-4. PubMed ID: 15921302
[TBL] [Abstract][Full Text] [Related]
20. Update: chronic myelogenous leukemia clinical practice guidelines.
O'Brien SM; Kantarjian H; Radich J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S29-40. PubMed ID: 19795574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
